Advanced Filters
noise

heart-transplantation Clinical Trials

A listing of heart-transplantation medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Found 58 clinical trials
L Laura Borgese

Diagnostic and Therapeutic Applications of Microarrays in Heart Transplantation

Demonstrate the impact of the Molecular Microscope Diagnostic System as the standard of care for heart transplant patients.

18 years of age All Phase N/A
B Brandon Johnson

Trifecta-Heart cfDNA-MMDx Study

Demonstrate the relationship between DD-cfDNA levels and HLA antibodies in blood transplant recipient and the Molecular Microscope® (MMDx) Diagnostic System results in indication and protocol biopsies from heart transplants.

years of age All Phase N/A
P Pooja Narayan, MS

Heart Transplantation - Renewal

Heart transplantation (HTx) is a well-established life-saving procedure but is associated with severe complications. Regular monitoring of heart transplant recipients is thus important for the early detection of these complications. Current standard clinical tests, however, rely on frequent invasive procedures including endomyocardial biopsies (EMB) and catheter angiography (Cath). In addition, …

years of age All Phase N/A

Intestinal Microsporidiosis in French Heart Transplant Recipients (CARMIC)

The investigators propose to carry out a national retrospective study to collect epidemiological, biological, clinical and therapeutic data on microsporidiosis among heart transplant patients.

years of age All Phase N/A
J Joo Myung Lee, MD, MPH, PhD

Physiologic Assessment of Microvascular Function in Heart Transplant Patients

The aim of the study is to evaluate the impact of early microvascular disease assessed by coronary physiologic indices such as fractional flow reserve (FFR), coronary flow reserve (CFR), index of microvascular resistance (IMR) on future occurrence of cardiac allograft vasculopathy (CAV) in heart transplant recipients.

18 - 85 years of age All Phase N/A
K Karl B Lemstrom, MD, PhD

Biomarkers for Diagnosis, Prognosis, and Targeted Therapy After Heart Transplantation

The objective of this prospective observational single center study is to investigate donor-derived cell-free DNA (ddcfDNA), peripheral blood platelet mRNA, peripheral blood extracellular vesicle mRNA, and peripheral blood leukocyte mRNA expression in recognition of clinically significant endomyocardial biopsy (EMB) proven acute rejection in human heart transplant recipients. In detail, the …

18 years of age All Phase N/A
G Georgina Fuertes, MDPHD

IMR-Heart Trasplant Study

Endomyocardial biopsy (EMB) is the gold standard method to guide post-heart trasplant (HT) patients, as it represents the best tool to identify rejection in orthotopic HT. However, it is frequently repeated during the first year, with some variations depending on each center protocol and it is potentially associated with serious …

18 years of age All Phase N/A

A Clinical Study of Association Between Postoperative Dyslipidemia and Organ Rejection in Transplant Patients

Abnormal lipid metabolism is a common complication after organ transplantation, with pathological changes in lipid parameters occurring in approximately 60-80% of cardiac transplant recipients receiving triple immunotherapy with cyclosporine, imid azathioprine, and methylprednisolone. With the significant increase in long-term survival and increasing age of transplant patients, atherosclerotic cardiovascular diseases, such …

18 years of age All Phase N/A
F Favio Herbas

US National OCS Heart Perfusion (OHP) Registry

This Registry is a sponsor initiated, multi-center, observational post-approval registry with independent academic oversight.

years of age All Phase N/A
L Luciano Potena, MD

Electronic Register on Advanced Heart Failure and Transplantation di Cuore

The goal of this observational study is to create an electronic registry of patients diagnosed with Advanced Heart Failure or Heart Transplant, starting from 01/01/1985 and to assess the incidence of Advanced Heart Failure and Heart Transplant, and characterize patients affected by the first or undergoing the second procedure, starting …

18 years of age All Phase N/A

Simplify language using AI